Clinical Trial Update: Nab-Sirolimus and Pazopanib Hydrochloride in Treating Patients With Advanced Nonadipocytic Soft Tissue Sarcomas [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating nab-sirolimus in combination with pazopanib in advanced soft tissue sarcoma (including locally advanced and metastatic cases) was t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Pazopanib hydrochloride (pazopanib)
• nab-sirolimus (sirolimus (nanoparticle albumin-bound formulation))

Snippet

Sponsor: University of Washington | Conditions: Advanced Soft Tissue Sarcoma, Locally Advanced Soft Tissue Sarcoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-03-13